RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @CMichaelGibson: Encouraging data for compassionate use of #Remdesivir in #coronavirus patients. 57% of those treated with extubated whi…
RT @megtirrell: From NEJM article on compassionate use of Gilead’s remdesivir, a breakdown of each patient’s improvement level https://t.co…
RT @andersskyrud: Hva skal liksom denne studien tilføre, og hvorfor er den publisert i NEJM? Den har ikke kontroll-arm og ville nesten uans…
A cohort is a Roman military unit of six centuries, one tenth of a legion.
RT @krychtiukmd: Compassionate Use of Remdesivir for Patients with Severe Covid-19 Analysis of 61 patients receiving #remdesivir for #COV…
RT @romeerizwan: Encouraging results with Remdesivir #COVID19 . ‘68% had an improvement in oxygen-support class, including 17 of 30 patient…
RT @megtirrell: From NEJM article on compassionate use of Gilead’s remdesivir, a breakdown of each patient’s improvement level https://t.co…
Compassionate Use of Remdesivir for Patients with Severe #COVIDー19 | @NEJM in this cohort of patients benefits were observed with use of Remdesivir. https://t.co/IusQrPHS2X
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Are these good enough news? I am not convinced. Really need to wait for the proper randomised clinical trials... #COVID19 https://t.co/T83efqugSq
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/Hb6djMQsTm
Nice to see a few cumulative records in there.
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @dr_michaelmarks: Conclusion Remdesivir #COVID19 @nejm https://t.co/oUKDAiA3SN Almost nil. >10% excluded analysis. No placebo/active com…
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…
RT @romeerizwan: Encouraging results with Remdesivir #COVID19 . ‘68% had an improvement in oxygen-support class, including 17 of 30 patient…
$GILD
Encouraging data for compassionate use of #Remdesivir in #coronavirus patients. 57% of those treated with extubated which compares favorably with 20% rates historically. RCTs ongoing as needed to characterize efficacy https://t.co/6DJ6Qdguk0 https://t.co/Y
Ok. Very ill patients. Now we need a control group. Waiting for #Discovery study results. But there may be something there. #remdisivir #SARSCoV2 #COVIDー19 #NEJM https://t.co/fCMEQVkJwz
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
I spoke with @AnitaMarks yesterday about many things including Remdesivir results that were due out any day
Conclusion Remdesivir #COVID19 @nejm https://t.co/oUKDAiA3SN Almost nil. >10% excluded analysis. No placebo/active comparator. Ignore til real data https://t.co/HF0w4o5m5o
RT @GermHunterMD: Here is a study. It is uncontrolled. It is not good. What are we doing here? https://t.co/FSyvKl3aPE
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @banavarrete: Acaba de salir el primer trabajo sobre Remdesivir en #COVID19 en @NEJM. Se trata de los datos de un programa de uso compas…
RT @CatiaCilloniz: Compassionate Use of Remdesivir for Patients with Severe #Covid-19 | NEJM https://t.co/kVEsWAS0tZ
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @ahmedjo70s: يالله يا ولاد خبر كويس أهو..ال Remdesivir بتاع جليد..الشركة اللي عملت أدوية ڤيروس سي..جايب نتيجة كويسة في الحالات الحادة ..…
RT @CatiaCilloniz: Compassionate Use of Remdesivir for Patients with Severe #Covid-19 | NEJM https://t.co/kVEsWAS0tZ
RT @neerajaiims: Just in @NEJM: Compassionate use of Remdesivir, a viral RNA polymerase inhibitor, results in clinical improvement in 68% h…
I'm going to leave the scientific analysis of this paper to scientists. But two thoughts... Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/wDhYsQSxxg
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @romeerizwan: Encouraging results with Remdesivir #COVID19 . ‘68% had an improvement in oxygen-support class, including 17 of 30 patient…
RT @rising_serpent: In this cohort of patients hospitalized for severe Covid19 who were treated with compassionate-use remdesivir, clinical…
@deCarvalhoAnd Vários perfis compartilhando esse estudo. https://t.co/cOaN18bINQ
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EMSwami: Interesting data on compassionate use Remdesivir in severe #COVID19 https://t.co/emNbrG4tVC Caution: not for all comers - Smal…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/0ZhFG5c2d9
Encouraging clinical results from remdesivir to treat very ill #COVID19 patients. Next: randomized, blinded, controlled trials (underway already).
Meget lovende forsøg med Remdesivir. @berlingske @Heunicke @LMSTSenderovitz @SSTSundhed
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Only 58 patients but 68% clinical improvement in severe #COVID19 patients with Remdesivir. https://t.co/kDdFjvkL3Q
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM. These legit medical studies (not tweets from crazy people) are my new Kenpom. Let’s go, doctors and scientists! https://t.co/nYx6A79rOY
RT @romeerizwan: Encouraging results with Remdesivir #COVID19 . ‘68% had an improvement in oxygen-support class, including 17 of 30 patient…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @neerajaiims: Just in @NEJM: Compassionate use of Remdesivir, a viral RNA polymerase inhibitor, results in clinical improvement in 68% h…
RT @Nat_anest: В NEJM сегодня опубликовали первый отчёт о применении Ремдесивира 53-и пациентам с тяжёлым течение Covid. Клиническое улучше…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @ahmedjo70s: يالله يا ولاد خبر كويس أهو..ال Remdesivir بتاع جليد..الشركة اللي عملت أدوية ڤيروس سي..جايب نتيجة كويسة في الحالات الحادة ..…
RT @accpinfdprn: 📄 New today from @NEJM on @GileadSciences’s remdesivir for #COVID19 📲 https://t.co/LPlhryLTAW No comparator. 68% had cl…
RT @megtirrell: From NEJM article on compassionate use of Gilead’s remdesivir, a breakdown of each patient’s improvement level https://t.co…
RT @AndyBiotech: NEJM report on compassionate use of Remdesivir for 53 patients with severe #COVID19 https://t.co/gL0QKtw39L … 36/53 (68%)…
RT @neerajaiims: Just in @NEJM: Compassionate use of Remdesivir, a viral RNA polymerase inhibitor, results in clinical improvement in 68% h…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…
Just in @NEJM: Compassionate use of Remdesivir, a viral RNA polymerase inhibitor, results in clinical improvement in 68% hospitalized patients (n=61) with severe COVID-19 infection. https://t.co/ShkCaBqcRc Hoping for a positive randomized trial needed down
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EdBelongia: Some encouraging news on remdesivir. This @NEJM analysis had no control group and is inconclusive, but outcomes were better…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @MoNscience: NEW #COVID19 #coronavirus study on antiviral remdesivir https://t.co/vSGto2tEzR Things to know: It's small (53 subjects).…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @JCarriel84: 🌍 Remdesivir (uso compasivo) en #COVID19 grave (SO2 <94%): 53 pctes (75%H, 64a prom, sgto 18d prom) -68% pctes mejoró O2 (5…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/0JeyMpjsp8
RT @ahmedjo70s: يالله يا ولاد خبر كويس أهو..ال Remdesivir بتاع جليد..الشركة اللي عملت أدوية ڤيروس سي..جايب نتيجة كويسة في الحالات الحادة ..…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Looks promising https://t.co/y20Y5Rl4Dk
RT @CatiaCilloniz: Compassionate Use of Remdesivir for Patients with Severe #Covid-19 | NEJM https://t.co/kVEsWAS0tZ
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Usage compassionnel de l'antiviral #Remdesivir chez des patients atteints de #COVID19 sévère. https://t.co/itjg0ougrR
Compassionate #remdisivir use (n=53) encouraging but doesn’t prove benefit in #COVID19. •Use criteria: O2 sat<94%, Cr clearance>30, LFTs<4x ULN •No comparison arm •13% mortality, 25% discharged, the rest still admitted (median f/u 18 days) •Safet
RT @rising_serpent: In this cohort of patients hospitalized for severe Covid19 who were treated with compassionate-use remdesivir, clinical…
NEW #COVID19 #coronavirus study on antiviral remdesivir https://t.co/vSGto2tEzR Things to know: It's small (53 subjects). 68% improved clinically, but there was no control group and they didn't measure viral load, so it's unclear if the drug was even wo
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…